本文選題：左房折疊術(shù)　切入點(diǎn)：二尖瓣置換　出處：《遵義醫(yī)學(xué)院》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:觀察二尖瓣置換同期行左心房折疊術(shù)后患者圍手術(shù)期心臟功能的變化,總結(jié)該類患者圍手術(shù)期治療經(jīng)驗(yàn),以期為該類患者的術(shù)后治療提供指導(dǎo)。方法:回顧性分析2015年1月到2016年12月在我院胸心血管外科行二尖瓣置換(MVR)并三尖瓣成形術(shù)和二尖瓣置換并三尖瓣成形同期行左房折疊術(shù)(LAP)患者的臨床資料,共176例,其中符合入選條件的病例共42例。根據(jù)患者是否同期行左房折疊術(shù)分為對(duì)照組和同期行LAP組各21例,對(duì)照組僅行二尖瓣置換并三尖瓣成形術(shù),同期行LAP組在行二尖瓣置換并三尖瓣成形術(shù)時(shí)同期行左房折疊術(shù)。觀察分析其升主動(dòng)脈阻斷時(shí)間(min)、體外循環(huán)時(shí)間(min)、術(shù)后ICU呼吸機(jī)輔助呼吸時(shí)間(h)、術(shù)后ICU治療時(shí)間(h)、術(shù)后住院時(shí)間(天)、術(shù)后當(dāng)天及術(shù)后3天血管活性藥物評(píng)分(VIS),術(shù)前及出院前心胸比(C/T)、左心房?jī)?nèi)徑、左心室射血分?jǐn)?shù)(LVEF)、左心室短軸縮短率(LVFS)。結(jié)果:1.同期行LAP組與對(duì)照組病人術(shù)前一般狀況無(wú)差異。2.升主動(dòng)脈阻斷時(shí)間、體外循環(huán)時(shí)間、術(shù)后呼吸機(jī)輔助呼吸時(shí)間、術(shù)后ICU治療時(shí)間對(duì)照組分別為53±12(min)、98±28(min)、28±19(h)、61±34(h),同期行LAP組分別為65±14(min)、108±26(min)、36±23(h)、72±38(h),兩組比較均有差異(P0.01)。3.術(shù)后住院天數(shù)對(duì)照組為12.63±4.11(天)、同期行LAP組為12.52±3.29(天),兩組比較無(wú)差異(P0.05)。4.術(shù)后當(dāng)天、第1天、第2天VIS評(píng)分對(duì)照組分別為15.28±4.41、12.42±4.01、8.26±3.11,同期行LAP組分別為19.68±6.32、18.42±5.72、11.32±3.64,兩組比較均有差異(P0.01);術(shù)后第3天VIS評(píng)分對(duì)照組為8.02±3.32、同期行LAP組為7.82±2.96,兩組比較無(wú)差異(P0.05)。5.術(shù)后左心房?jī)?nèi)徑對(duì)照組為69±11(mm)、同期行LAP組為62±8(mm),兩組比較有差異(P0.01)。6.術(shù)后C/T對(duì)照組為0.66±0.04、同期行LAP組為0.59±0.03,兩組比較有差異(P0.05)。7.術(shù)后LVEF值對(duì)照組為59±4.6(%)、同期行LAP組為65±3.2(%),兩組比較有差異(P0.05);術(shù)后LVFS值對(duì)照組為33±2.9(%)、同期行LAP組為37±2.8(%),兩組比較有差異(P0.05)。結(jié)論:二尖瓣置換三尖瓣成形術(shù)同期行左房折疊術(shù),可顯著減小術(shù)后左心房?jī)?nèi)徑和C/T,明顯縮小左心房,減輕GLA對(duì)周圍器官組織的壓迫,改善圍手術(shù)期GLA患者的心功能。左心房折疊術(shù)可能加重心臟損傷、短暫影響心功能,術(shù)后3天內(nèi)需要較多、較大劑量血管活性藥物支持治療,同時(shí)需要適當(dāng)延長(zhǎng)呼吸機(jī)輔助呼吸時(shí)間及ICU治療時(shí)間,但經(jīng)圍手術(shù)期治療心功能能夠較快恢復(fù)。
[Abstract]:Objective: to observe the perioperative changes of cardiac function in patients undergoing mitral valve replacement and left atrial folding, and to summarize the experience of perioperative treatment in patients with mitral valve replacement. Methods: from January 2015 to December 2016, mitral valve replacement (MVR) and tricuspid valvuloplasty combined with tricuspid valvuloplasty and tricuspid valvuloplasty were performed in our hospital from January 2015 to December 2016. Clinical data of patients undergoing left atrial folding (LAP), The patients were divided into two groups: control group (n = 21) and LAP group (n = 21). The control group was treated with mitral valve replacement and tricuspid valvuloplasty. In LAP group, mitral valve replacement and tricuspid valvuloplasty were performed simultaneously with left atrial folding. The time of ascending aorta occlusion, cardiopulmonary bypass, ICU ventilator assisted respiration and ICU treatment were observed and analyzed. Postoperative hospitalization time (day and day), vasoactive drug score (Vis) on the day of operation and 3 days after operation, heart and chest ratio before and before discharge, left atrial diameter, left atrial diameter, left atrium diameter, left atrium diameter, left atrium diameter, left atrial diameter, left atrium diameter, left atrium diameter, Left ventricular ejection fraction (LVEF), left ventricular short axis shortening rate (LVEF) and left ventricular shortening rate (LVFS). Results: there was no significant difference in preoperative general status between LAP group and control group. 2. Time of ascending aorta occlusion, time of cardiopulmonary bypass, time of ventilator assisted respiration after operation. The duration of postoperative ICU treatment in the control group was 53 鹵12 minutes, 98 鹵28 minutes and 28 鹵19 minutes, respectively, and that in the LAP group was 65 鹵14 minutes, 108 鹵26 minutes, 36 鹵23 minutes, 72 鹵38 minutes, respectively. The postoperative hospitalization days were 12.63 鹵4.11 days in the control group and 12.52 鹵3.29 days in the LAP group, respectively. There was no difference between the two groups on the first day after operation, and there was no significant difference between the two groups on the first day after operation. On the second day, the VIS score of the control group was 15.28 鹵4.41 鹵4.01 鹵4.01 鹵8.26 鹵3.11, and that of the LAP group was 19.68 鹵6.32 鹵5.72 鹵11.32 鹵3.64, respectively. The VIS score of the control group was 8.02 鹵3.32 on the 3rd day after operation, and that of the LAP group was 7.82 鹵2.96. There was no significant difference in the internal diameter of left atrium between the two groups. The difference between the two groups was found between the two groups (P < 0.01). The C / T control group was 0.66 鹵0.04, and the LAP group was 0.59 鹵0.03, there was significant difference between the two groups. The LVEF value was 59 鹵4.6 in the control group and 65 鹵3.2 in the LAP group, respectively, and there was a significant difference between the two groups in the postoperative LVFS value in the control group (P 0.05). The value of mitral valve replacement was 33 鹵2.9 and that of LAP group was 37 鹵2.8. Conclusion: mitral valve replacement tricuspid valvuloplasty and tricuspid valve replacement were performed simultaneously with left atrial folding, and there was a significant difference between the two groups. It can significantly reduce the left atrial diameter and C / T, reduce the pressure of GLA on peripheral organs and tissues, and improve the cardiac function of patients with GLA during perioperative period. During the 3 days after operation, a large dose of vasoactive drugs should be used to support the treatment, and the time of ventilator assisted breathing and ICU should be prolonged properly. However, the cardiac function could recover quickly in the perioperative period.
【學(xué)位授予單位】：遵義醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R654.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 繆維洲;;幼兒及兒童的二尖瓣置換[J];國(guó)外醫(yī)學(xué)(兒科學(xué)分冊(cè));1982年06期

2 張杰民,喬建華,趙洪序,宋翔翎;巨大心臟二尖瓣置換成功一例[J];白求恩醫(yī)科大學(xué)學(xué)報(bào);1992年02期

3 滕和志;王向麗;秦春新;李文曉;陳艷;郭志勇;;36例小左心室患者二尖瓣置換治療體會(huì)[J];中國(guó)醫(yī)藥;2006年04期

4 梁凱;張瑞成;朱汝軍;王平凡;;二尖瓣置換同期行房顫射頻消融手術(shù)的療效研究[J];中國(guó)醫(yī)藥指南;2012年29期

5 黃達(dá)德;楊愛(ài)蓮;陳文廣;張年偉;;右前外剖胸股動(dòng)脈——右房轉(zhuǎn)流再次二尖瓣置換(附3例報(bào)告)[J];廣州醫(yī)藥;1992年05期

6 鐘衛(wèi)權(quán),黃志堅(jiān),肖勁莎,陳業(yè)煌;再次手術(shù)二尖瓣置換有關(guān)問(wèn)題探討[J];南華大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2002年02期

7 胡小菊;史宏偉;;二尖瓣置換患者圍術(shù)期心功能不全的臨床研究進(jìn)展[J];醫(yī)學(xué)研究生學(xué)報(bào);2013年03期

8 劉曉莉,朱學(xué)敏,龔桂芝;再次手術(shù)二尖瓣置換術(shù)后監(jiān)護(hù)[J];護(hù)理學(xué)雜志;1997年02期

9 安君;王巍;王嵩;秦瑤;史宏?duì)N;;二尖瓣置換加迷宮手術(shù)中發(fā)生電風(fēng)暴一例[J];中國(guó)胸心血管外科臨床雜志;2010年05期

10 鄭黔源;;二尖瓣置換治療青少年風(fēng)濕性心臟病(附118例早晚期療效)[J];貴州醫(yī)藥;1986年06期

相關(guān)會(huì)議論文 前4條

1 楊麗華;周晴;任曼曼;;二尖瓣置換圍術(shù)期護(hù)理要點(diǎn)[A];河南省護(hù)理學(xué)會(huì)外科急危重病人監(jiān)護(hù)學(xué)術(shù)交流會(huì)資料匯編[C];2006年

2 王睿;陳鑫;石開(kāi)虎;徐明;蔣英碩;劉培生;肖立瓊;;肥厚室間隔切除聯(lián)合二尖瓣置換治療肥厚性梗阻型心肌病[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)胸心血管外科學(xué)術(shù)會(huì)議暨2007中華醫(yī)學(xué)會(huì)胸心血管外科青年醫(yī)師論壇論文集心血管外科分冊(cè)[C];2007年

3 葉敏華;朱成楚;葉加洪;葉中瑞;陳保富;;胸腔鏡二尖瓣置換3例[A];2006年浙江省胸心外科學(xué)術(shù)會(huì)議論文匯編[C];2006年

4 王志農(nóng);徐志云;王爾松;鄒良建;梅舉;郝家驊;張寶仁;;同期室間隔心肌切除和二尖瓣置換治療肥厚型梗阻性心肌病的療效[A];第八屆華東六省一市胸心血管外科學(xué)術(shù)會(huì)議論文匯編[C];2005年

相關(guān)重要報(bào)紙文章 前1條

1 張秀花;“嗜鉻細(xì)胞瘤” 患者二尖瓣置換成功[N];中國(guó)醫(yī)藥報(bào);2008年

相關(guān)博士學(xué)位論文 前1條

1 王強(qiáng);單純二尖瓣置換綜合分析及危險(xiǎn)因素探討[D];第二軍醫(yī)大學(xué);2011年

相關(guān)碩士學(xué)位論文 前7條

1 胡鵬程;二尖瓣置換同期行左心房折疊術(shù)在圍手術(shù)期的觀察與處理[D];遵義醫(yī)學(xué)院;2017年

2 宋毅;人工二尖瓣置換病人術(shù)后早期血小板聚集性研究[D];第三軍醫(yī)大學(xué);2010年

3 張玉京;二尖瓣置換圍手術(shù)期危險(xiǎn)因素分析[D];寧夏醫(yī)科大學(xué);2013年

4 黃棟;不同構(gòu)型人工瓣二尖瓣置換豬模型建立的實(shí)驗(yàn)研究（國(guó)家自然科學(xué)基金資助項(xiàng)目）[D];昆明醫(yī)學(xué)院;2011年

5 王新利;改良GIK改善二尖瓣置換病人胰島素抵抗及臟器保護(hù)作用的研究[D];第四軍醫(yī)大學(xué);2012年

6 張正剛;二尖瓣置換同期房顫雙極射頻消融圍術(shù)期血清NT-proBNP變化及臨床意義[D];遵義醫(yī)學(xué)院;2012年

7 竇寧;H_2在心臟二尖瓣瓣膜置換術(shù)中對(duì)心肌的保護(hù)作用的研究[D];寧夏醫(yī)科大學(xué);2012年

，

本文編號(hào)：1611097